Open1.480 | Close- |
Vol / Avg.28.805K / 37.384K | Mkt Cap11.682M |
Day Range1.340 - 1.480 | 52 Wk Range1.000 - 3.400 |
Organovo Holdings Stock (NASDAQ: ONVO) stock price, news, charts, stock research, profile.
Open1.480 | Close- |
Vol / Avg.28.805K / 37.384K | Mkt Cap11.682M |
Day Range1.340 - 1.480 | 52 Wk Range1.000 - 3.400 |
Q2 2024 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q1 2024 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.460 | ||||||
REV | 75.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2019-08-08 | HC Wainwright & Co. | - | Downgrades | BuyNeutral | - | - | - |
2018-12-13 | HC Wainwright & Co. | - | Initiates Coverage On | Buy | Announces | - | 2.50 |
2017-11-10 | Raymond James | Reni Benjamin | Downgrades | OutperformMarket Perform | - | 5.00 | - |
2017-01-25 | Raymond James | Reni Benjamin | Initiates Coverage On | Outperform | Announces | - | 5.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ONVO | Organovo Holdings | -5.63% | 11.7M |
ERNA | Eterna Therapeutics | -0.48% | 11.2M |
IMPL | Impel Pharmaceuticals | 3.99% | 13M |
IMRN | Immuron | -1.53% | 10.9M |
DOMH | Dominari Holdings | 0.41% | 13M |
You can purchase shares of Organovo Holdings (NASDAQ: ONVO) through any online brokerage.
Other companies in Organovo Holdings’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Impel Pharmaceuticals (NASDAQ:IMPL), Immuron (NASDAQ:IMRN), Dominari Holdings (NASDAQ:DOMH) and Imunon (NASDAQ:IMNN).
The latest price target for Organovo Holdings (NASDAQ: ONVO) was reported by HC Wainwright & Co. on Thursday, August 8, 2019. The analyst firm set a price target for 0.00 expecting ONVO to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Organovo Holdings (NASDAQ: ONVO) is $1.34 last updated Today at September 22, 2023 at 6:58 PM UTC.
There is no dividend information for Organovo Holdings.
Organovo Holdings’s Q2 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Organovo Holdings.
Organovo Holdings is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Organovo Holdings Stock (NASDAQ: ONVO) stock price, news, charts, stock research, profile.
Open1.480 | Close- |
Vol / Avg.28.805K / 37.384K | Mkt Cap11.682M |
Day Range1.340 - 1.480 | 52 Wk Range1.000 - 3.400 |
Q2 2024 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q1 2024 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.460 | ||||||
REV | 75.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2019-08-08 | HC Wainwright & Co. | - | Downgrades | BuyNeutral | - | - | - |
2018-12-13 | HC Wainwright & Co. | - | Initiates Coverage On | Buy | Announces | - | 2.50 |
2017-11-10 | Raymond James | Reni Benjamin | Downgrades | OutperformMarket Perform | - | 5.00 | - |
2017-01-25 | Raymond James | Reni Benjamin | Initiates Coverage On | Outperform | Announces | - | 5.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ONVO | Organovo Holdings | -5.63% | 11.7M |
ERNA | Eterna Therapeutics | -0.48% | 11.2M |
IMPL | Impel Pharmaceuticals | 3.99% | 13M |
IMRN | Immuron | -1.53% | 10.9M |
DOMH | Dominari Holdings | 0.41% | 13M |
You can purchase shares of Organovo Holdings (NASDAQ: ONVO) through any online brokerage.
Other companies in Organovo Holdings’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Impel Pharmaceuticals (NASDAQ:IMPL), Immuron (NASDAQ:IMRN), Dominari Holdings (NASDAQ:DOMH) and Imunon (NASDAQ:IMNN).
The latest price target for Organovo Holdings (NASDAQ: ONVO) was reported by HC Wainwright & Co. on Thursday, August 8, 2019. The analyst firm set a price target for 0.00 expecting ONVO to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Organovo Holdings (NASDAQ: ONVO) is $1.34 last updated Today at September 22, 2023 at 6:58 PM UTC.
There is no dividend information for Organovo Holdings.
Organovo Holdings’s Q2 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Organovo Holdings.
Organovo Holdings is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Organovo Holdings Stock (NASDAQ: ONVO) stock price, news, charts, stock research, profile.
Open1.480 | Close- |
Vol / Avg.28.805K / 37.384K | Mkt Cap11.682M |
Day Range1.340 - 1.480 | 52 Wk Range1.000 - 3.400 |
Q2 2024 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q1 2024 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.460 | ||||||
REV | 75.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2019-08-08 | HC Wainwright & Co. | - | Downgrades | BuyNeutral | - | - | - |
2018-12-13 | HC Wainwright & Co. | - | Initiates Coverage On | Buy | Announces | - | 2.50 |
2017-11-10 | Raymond James | Reni Benjamin | Downgrades | OutperformMarket Perform | - | 5.00 | - |
2017-01-25 | Raymond James | Reni Benjamin | Initiates Coverage On | Outperform | Announces | - | 5.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ONVO | Organovo Holdings | -5.63% | 11.7M |
ERNA | Eterna Therapeutics | -0.48% | 11.2M |
IMPL | Impel Pharmaceuticals | 3.99% | 13M |
IMRN | Immuron | -1.53% | 10.9M |
DOMH | Dominari Holdings | 0.41% | 13M |
You can purchase shares of Organovo Holdings (NASDAQ: ONVO) through any online brokerage.
Other companies in Organovo Holdings’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Impel Pharmaceuticals (NASDAQ:IMPL), Immuron (NASDAQ:IMRN), Dominari Holdings (NASDAQ:DOMH) and Imunon (NASDAQ:IMNN).
The latest price target for Organovo Holdings (NASDAQ: ONVO) was reported by HC Wainwright & Co. on Thursday, August 8, 2019. The analyst firm set a price target for 0.00 expecting ONVO to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Organovo Holdings (NASDAQ: ONVO) is $1.34 last updated Today at September 22, 2023 at 6:58 PM UTC.
There is no dividend information for Organovo Holdings.
Organovo Holdings’s Q2 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Organovo Holdings.
Organovo Holdings is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Organovo Holdings Stock (NASDAQ: ONVO) stock price, news, charts, stock research, profile.
Open1.480 | Close- |
Vol / Avg.28.805K / 37.384K | Mkt Cap11.682M |
Day Range1.340 - 1.480 | 52 Wk Range1.000 - 3.400 |
Q2 2024 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q1 2024 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.460 | ||||||
REV | 75.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2019-08-08 | HC Wainwright & Co. | - | Downgrades | BuyNeutral | - | - | - |
2018-12-13 | HC Wainwright & Co. | - | Initiates Coverage On | Buy | Announces | - | 2.50 |
2017-11-10 | Raymond James | Reni Benjamin | Downgrades | OutperformMarket Perform | - | 5.00 | - |
2017-01-25 | Raymond James | Reni Benjamin | Initiates Coverage On | Outperform | Announces | - | 5.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ONVO | Organovo Holdings | -5.63% | 11.7M |
ERNA | Eterna Therapeutics | -0.48% | 11.2M |
IMPL | Impel Pharmaceuticals | 3.99% | 13M |
IMRN | Immuron | -1.53% | 10.9M |
DOMH | Dominari Holdings | 0.41% | 13M |
You can purchase shares of Organovo Holdings (NASDAQ: ONVO) through any online brokerage.
Other companies in Organovo Holdings’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Impel Pharmaceuticals (NASDAQ:IMPL), Immuron (NASDAQ:IMRN), Dominari Holdings (NASDAQ:DOMH) and Imunon (NASDAQ:IMNN).
The latest price target for Organovo Holdings (NASDAQ: ONVO) was reported by HC Wainwright & Co. on Thursday, August 8, 2019. The analyst firm set a price target for 0.00 expecting ONVO to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Organovo Holdings (NASDAQ: ONVO) is $1.34 last updated Today at September 22, 2023 at 6:58 PM UTC.
There is no dividend information for Organovo Holdings.
Organovo Holdings’s Q2 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Organovo Holdings.
Organovo Holdings is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Organovo Holdings Stock (NASDAQ: ONVO) stock price, news, charts, stock research, profile.
Open1.480 | Close- |
Vol / Avg.28.805K / 37.384K | Mkt Cap11.682M |
Day Range1.340 - 1.480 | 52 Wk Range1.000 - 3.400 |
Q2 2024 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q1 2024 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.460 | ||||||
REV | 75.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2019-08-08 | HC Wainwright & Co. | - | Downgrades | BuyNeutral | - | - | - |
2018-12-13 | HC Wainwright & Co. | - | Initiates Coverage On | Buy | Announces | - | 2.50 |
2017-11-10 | Raymond James | Reni Benjamin | Downgrades | OutperformMarket Perform | - | 5.00 | - |
2017-01-25 | Raymond James | Reni Benjamin | Initiates Coverage On | Outperform | Announces | - | 5.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ONVO | Organovo Holdings | -5.63% | 11.7M |
ERNA | Eterna Therapeutics | -0.48% | 11.2M |
IMPL | Impel Pharmaceuticals | 3.99% | 13M |
IMRN | Immuron | -1.53% | 10.9M |
DOMH | Dominari Holdings | 0.41% | 13M |
You can purchase shares of Organovo Holdings (NASDAQ: ONVO) through any online brokerage.
Other companies in Organovo Holdings’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Impel Pharmaceuticals (NASDAQ:IMPL), Immuron (NASDAQ:IMRN), Dominari Holdings (NASDAQ:DOMH) and Imunon (NASDAQ:IMNN).
The latest price target for Organovo Holdings (NASDAQ: ONVO) was reported by HC Wainwright & Co. on Thursday, August 8, 2019. The analyst firm set a price target for 0.00 expecting ONVO to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Organovo Holdings (NASDAQ: ONVO) is $1.34 last updated Today at September 22, 2023 at 6:58 PM UTC.
There is no dividend information for Organovo Holdings.
Organovo Holdings’s Q2 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Organovo Holdings.
Organovo Holdings is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Organovo Holdings Stock (NASDAQ: ONVO) stock price, news, charts, stock research, profile.
Open1.480 | Close- |
Vol / Avg.28.805K / 37.384K | Mkt Cap11.682M |
Day Range1.340 - 1.480 | 52 Wk Range1.000 - 3.400 |
Q2 2024 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q1 2024 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.460 | ||||||
REV | 75.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2019-08-08 | HC Wainwright & Co. | - | Downgrades | BuyNeutral | - | - | - |
2018-12-13 | HC Wainwright & Co. | - | Initiates Coverage On | Buy | Announces | - | 2.50 |
2017-11-10 | Raymond James | Reni Benjamin | Downgrades | OutperformMarket Perform | - | 5.00 | - |
2017-01-25 | Raymond James | Reni Benjamin | Initiates Coverage On | Outperform | Announces | - | 5.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ONVO | Organovo Holdings | -5.63% | 11.7M |
ERNA | Eterna Therapeutics | -0.48% | 11.2M |
IMPL | Impel Pharmaceuticals | 3.99% | 13M |
IMRN | Immuron | -1.53% | 10.9M |
DOMH | Dominari Holdings | 0.41% | 13M |
You can purchase shares of Organovo Holdings (NASDAQ: ONVO) through any online brokerage.
Other companies in Organovo Holdings’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Impel Pharmaceuticals (NASDAQ:IMPL), Immuron (NASDAQ:IMRN), Dominari Holdings (NASDAQ:DOMH) and Imunon (NASDAQ:IMNN).
The latest price target for Organovo Holdings (NASDAQ: ONVO) was reported by HC Wainwright & Co. on Thursday, August 8, 2019. The analyst firm set a price target for 0.00 expecting ONVO to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Organovo Holdings (NASDAQ: ONVO) is $1.34 last updated Today at September 22, 2023 at 6:58 PM UTC.
There is no dividend information for Organovo Holdings.
Organovo Holdings’s Q2 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Organovo Holdings.
Organovo Holdings is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Organovo Holdings Stock (NASDAQ: ONVO) stock price, news, charts, stock research, profile.
Open1.480 | Close- |
Vol / Avg.28.805K / 37.384K | Mkt Cap11.682M |
Day Range1.340 - 1.480 | 52 Wk Range1.000 - 3.400 |
Q2 2024 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q1 2024 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.460 | ||||||
REV | 75.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2019-08-08 | HC Wainwright & Co. | - | Downgrades | BuyNeutral | - | - | - |
2018-12-13 | HC Wainwright & Co. | - | Initiates Coverage On | Buy | Announces | - | 2.50 |
2017-11-10 | Raymond James | Reni Benjamin | Downgrades | OutperformMarket Perform | - | 5.00 | - |
2017-01-25 | Raymond James | Reni Benjamin | Initiates Coverage On | Outperform | Announces | - | 5.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ONVO | Organovo Holdings | -5.63% | 11.7M |
ERNA | Eterna Therapeutics | -0.48% | 11.2M |
IMPL | Impel Pharmaceuticals | 3.99% | 13M |
IMRN | Immuron | -1.53% | 10.9M |
DOMH | Dominari Holdings | 0.41% | 13M |
You can purchase shares of Organovo Holdings (NASDAQ: ONVO) through any online brokerage.
Other companies in Organovo Holdings’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Impel Pharmaceuticals (NASDAQ:IMPL), Immuron (NASDAQ:IMRN), Dominari Holdings (NASDAQ:DOMH) and Imunon (NASDAQ:IMNN).
The latest price target for Organovo Holdings (NASDAQ: ONVO) was reported by HC Wainwright & Co. on Thursday, August 8, 2019. The analyst firm set a price target for 0.00 expecting ONVO to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Organovo Holdings (NASDAQ: ONVO) is $1.34 last updated Today at September 22, 2023 at 6:58 PM UTC.
There is no dividend information for Organovo Holdings.
Organovo Holdings’s Q2 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Organovo Holdings.
Organovo Holdings is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Organovo Holdings Stock (NASDAQ: ONVO) stock price, news, charts, stock research, profile.
Open1.480 | Close- |
Vol / Avg.28.805K / 37.384K | Mkt Cap11.682M |
Day Range1.340 - 1.480 | 52 Wk Range1.000 - 3.400 |
Q2 2024 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q1 2024 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.460 | ||||||
REV | 75.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2019-08-08 | HC Wainwright & Co. | - | Downgrades | BuyNeutral | - | - | - |
2018-12-13 | HC Wainwright & Co. | - | Initiates Coverage On | Buy | Announces | - | 2.50 |
2017-11-10 | Raymond James | Reni Benjamin | Downgrades | OutperformMarket Perform | - | 5.00 | - |
2017-01-25 | Raymond James | Reni Benjamin | Initiates Coverage On | Outperform | Announces | - | 5.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ONVO | Organovo Holdings | -5.63% | 11.7M |
ERNA | Eterna Therapeutics | -0.48% | 11.2M |
IMPL | Impel Pharmaceuticals | 3.99% | 13M |
IMRN | Immuron | -1.53% | 10.9M |
DOMH | Dominari Holdings | 0.41% | 13M |
You can purchase shares of Organovo Holdings (NASDAQ: ONVO) through any online brokerage.
Other companies in Organovo Holdings’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Impel Pharmaceuticals (NASDAQ:IMPL), Immuron (NASDAQ:IMRN), Dominari Holdings (NASDAQ:DOMH) and Imunon (NASDAQ:IMNN).
The latest price target for Organovo Holdings (NASDAQ: ONVO) was reported by HC Wainwright & Co. on Thursday, August 8, 2019. The analyst firm set a price target for 0.00 expecting ONVO to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Organovo Holdings (NASDAQ: ONVO) is $1.34 last updated Today at September 22, 2023 at 6:58 PM UTC.
There is no dividend information for Organovo Holdings.
Organovo Holdings’s Q2 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Organovo Holdings.
Organovo Holdings is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Organovo Holdings Stock (NASDAQ: ONVO) stock price, news, charts, stock research, profile.
Open1.480 | Close- |
Vol / Avg.28.805K / 37.384K | Mkt Cap11.682M |
Day Range1.340 - 1.480 | 52 Wk Range1.000 - 3.400 |
Q2 2024 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q1 2024 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.460 | ||||||
REV | 75.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2019-08-08 | HC Wainwright & Co. | - | Downgrades | BuyNeutral | - | - | - |
2018-12-13 | HC Wainwright & Co. | - | Initiates Coverage On | Buy | Announces | - | 2.50 |
2017-11-10 | Raymond James | Reni Benjamin | Downgrades | OutperformMarket Perform | - | 5.00 | - |
2017-01-25 | Raymond James | Reni Benjamin | Initiates Coverage On | Outperform | Announces | - | 5.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ONVO | Organovo Holdings | -5.63% | 11.7M |
ERNA | Eterna Therapeutics | -0.48% | 11.2M |
IMPL | Impel Pharmaceuticals | 3.99% | 13M |
IMRN | Immuron | -1.53% | 10.9M |
DOMH | Dominari Holdings | 0.41% | 13M |
You can purchase shares of Organovo Holdings (NASDAQ: ONVO) through any online brokerage.
Other companies in Organovo Holdings’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Impel Pharmaceuticals (NASDAQ:IMPL), Immuron (NASDAQ:IMRN), Dominari Holdings (NASDAQ:DOMH) and Imunon (NASDAQ:IMNN).
The latest price target for Organovo Holdings (NASDAQ: ONVO) was reported by HC Wainwright & Co. on Thursday, August 8, 2019. The analyst firm set a price target for 0.00 expecting ONVO to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Organovo Holdings (NASDAQ: ONVO) is $1.34 last updated Today at September 22, 2023 at 6:58 PM UTC.
There is no dividend information for Organovo Holdings.
Organovo Holdings’s Q2 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Organovo Holdings.
Organovo Holdings is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.